Shareholders Reject Key Bylaw Amendments Tied to New Control Structure
Summary
Braskem shareholders rejected key bylaw amendments intended to align the company's governance with a recently announced new Shareholders Agreement and control structure.
Key Events
-
Shareholders Reject Bylaw Amendments
Shareholders voted against proposed amendments to articles 11, 12, 14, 17-23, 25-33, 36-38, 40, 41, 44, and 49 of the company's bylaws.
-
Impact on New Shareholders Agreement
The rejected amendments were crucial for reflecting the provisions of the new Shareholders Agreement, which was disclosed in a Material Fact on April 23, 2026, and for implementing new governance practices.
-
Governance Changes Stalled
The vote also stalled the incorporation of new statutory committees (Finance and Investment; Strategy, Sustainability and Communication; People and Organization; Safety, Environment and Health) and adjustments to the Board of Directors and Executive Board.
-
Context of Recent Ownership Change
This rejection follows the definitive agreement for Novonor to sell a 34.3% stake to Shine I Fundo de Investimento, formalizing shared control, making the governance alignment critical.
Analysis
Braskem shareholders rejected proposed bylaw amendments, specifically those intended to reflect the new Shareholders Agreement and implement new governance practices. This outcome creates significant uncertainty for the company, especially given its recent major ownership change and ongoing financial distress, potentially complicating efforts to stabilize and implement its new strategic direction.
At the time of this filing, BAK was trading at $3.60 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $2.32 to $5.40. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.